SCCF Q4 2025 Earnings Massive EPS Surprise of 782 Driven by Strong Operational Performance Amicus Therapeutics Q4 2025 Earnings EPS Misses Expectations by a Wide Margin DGXX Q3 2025 Earnings Loss Per Share of 003 as Company Navigates Challenging Environment KEP Q4 2025 Earnings EPS Miss Amid Operational Challenges Farmers Merchants Bancorp Inc FMAO Q1 2026 Earnings EPS Beats Estimates by 381 Amidst Market Pressure Ernexa Therapeutics Q3 2023 Earnings Losses Deepen as Stock Declines No Revenue Reported